Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Blinded Drug

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCGI1491

07/15/2015

A Double-Blind, Randomised, Placebo Controlled Phase III Study of Nintedanib plus Best Supportive Care (BSC) versus Placebo Plus BSC in Patients with Colorectal Cancer Refractory to Standard Therapies.